| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | CAY10618 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | cabozantinib | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | ML050 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | BRD-K26531177 | CTRPv2 | pan-cancer | AAC | -0.0015 | 1 |